首页> 外文期刊>Journal of Microbiology and Infectious Diseases >Abstract - Epidemiology of carbapenemase producing Enterobacteriaceae in a general hospital
【24h】

Abstract - Epidemiology of carbapenemase producing Enterobacteriaceae in a general hospital

机译:摘要-综合医院生产碳青霉烯酶的肠杆菌科的流行病学

获取原文
           

摘要

Objective Detect the presence of carbapenemases producing Enterobacteriaceae (CPE) and associated epidemiologi­cal, microbiological, and clinical characteristics of patients in our hospital Methods During 15 months period, all non duplicate Enterobacteriaceae isolates with reduced susceptibility to car­bapenem detected by MicroScan WalkAway system and confirmed by E test were collected. These suspected isolates were further screened by modified Hodge test and carbapenemase inhibition discs to identify CPE. Results Out of 54 suspected Enterobacteriaceae isolates, 44 (88.5%) isolates were either extended spectrum beta-lac­tamases (ESBLs) or AmpC producers with porin loss whereas 10 isolates (18.5%) were confirmed to produce carbapen­emase representing (0.74%) of the total Enterobacteriaceae. Among these 10 isolates, 6 were OXA 48 producers and 2 isolates were class B and class A each. Six out of the 10 CPE were detected in ICU and specimen source was tracheal aspirate in 5 CPE isolates. All CPE isolates were sensitive to colistin and all but one to tigecycline. All patients had history of previous antibiotic exposure and hospital stays for more than 5 days. Conclusion Although CPE is not the main cause of carbapenem resistance in Enterobacteriaceae in our setting, its emergence there represents a serious infection control and therapeutic challenge. This mandates its early detection using MHT and carbapenemase inhibition tests together with strict infection control measures to limit its spread. J Mi­crobiol Infect Dis 2015;5(2) 57-62 Amina Kandeel,Department of Medical Microbiology and Immunology, Faculty of Medicine, Mansoura University, Egyp, Epidemiology of carbapenemase producing Enterobacteriaceae in a general hospital, Amina Kandeel, Department of Medical Microbiology and Immunology, Faculty of Medicine, Mansoura University, Egyp, J Microbiol Infect Dis 2015; 5(2) 57-62 doi 10.5799/ahinjs.02.2015.02.0177 Volume 05, Number 02 (2015)
机译:目的检测我院患者产生肠杆菌科(CPE)的碳青霉烯酶的存在及其相关的流行病学,微生物学和临床特征方法在15个月的时间内,通过MicroScan WalkAway系统检测并通过E确认的所有非重复性肠杆菌科细菌对碳青霉烯的敏感性降低测试被收集。通过改良的Hodge试验和碳青霉烯酶抑制片进一步筛选这些可疑分离株,以鉴定CPE。结果在54株疑似肠杆菌科细菌中,有44株(88.5%)属于扩大谱的β-内酰胺酶(ESBLs)或AmpC产生者的孔蛋白丢失,而10株(18.5%)的细菌被证实产生碳青霉烯酶,占总数的0.74%。肠杆菌科。在这10个分离株中,有6个是OXA 48生产者,有2个分离株分别是B类和A类。在ICU中检测到10例CPE中的6例,标本来源是5例CPE分离物中的气管抽吸物。所有CPE分离株均对大肠菌素敏感,除替加环素以外对所有细菌敏感。所有患者都曾有过抗生素暴露史,并且住院时间超过5天。结论尽管在我们的研究中,CPE不是肠杆菌科对碳青霉烯耐药的主要原因,但它的出现代表了严重的感染控制和治疗挑战。这要求使用MHT和碳青霉烯酶抑制试验及严格的感染控制措施来尽早发现,以限制其传播。 J Microbiol Infect Dis 2015; 5(2)57-62 Amina Kandeel,曼苏拉大学医学院医学微生物学和免疫学系,埃及,总医院产碳青霉烯酶的肠杆菌科流行病学,Amina Kandeel,医学微生物学和医学系曼苏拉大学医学院免疫学,埃及,《微生物感染杂志》,2015年; 5(2)57-62 doi 10.5799 / ahinjs.02.2015.02.0177第05卷,第02期(2015)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号